These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 29089065)
1. A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries. Cavalleri D; Murphy M; Seewald W; Drake J; Nanchen S Parasit Vectors; 2017 Nov; 10(1):526. PubMed ID: 29089065 [TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA. Karadzovska D; Chappell K; Coble S; Murphy M; Cavalleri D; Wiseman S; Drake J; Nanchen S Parasit Vectors; 2017 Nov; 10(1):528. PubMed ID: 29089063 [TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling fleas in client-owned cats in Europe. Cavalleri D; Murphy M; Seewald W; Nanchen S Parasit Vectors; 2018 Jul; 11(1):410. PubMed ID: 30001744 [TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™ CAT) in eliminating fleas in client-owned cats in the USA. Chappell K; Paarlberg T; Seewald W; Karadzovska D; Nanchen S Parasit Vectors; 2021 Mar; 14(1):127. PubMed ID: 33648556 [TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned dogs in Europe. Cavalleri D; Murphy M; Seewald W; Drake J; Nanchen S Parasit Vectors; 2017 Nov; 10(1):531. PubMed ID: 29089058 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™) in the treatment of naturally occurring flea and tick infestations in dogs presented as veterinary patients in Europe. Becskei C; De Bock F; Illambas J; Mahabir SP; Farkas R; Six RH Vet Parasitol; 2016 May; 222():49-55. PubMed ID: 26994516 [TBL] [Abstract][Full Text] [Related]
7. Assessment of the onset of lotilaner (Credelio™) speed of kill of fleas on dogs. Cavalleri D; Murphy M; Seewald W; Drake J; Nanchen S Parasit Vectors; 2017 Nov; 10(1):521. PubMed ID: 29089066 [TBL] [Abstract][Full Text] [Related]
8. Assessment of the speed of flea kill of lotilaner (Credelio™) throughout the month following oral administration to dogs. Cavalleri D; Murphy M; Seewald W; Drake J; Nanchen S Parasit Vectors; 2017 Nov; 10(1):529. PubMed ID: 29089019 [TBL] [Abstract][Full Text] [Related]
9. Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio Forster S; Wiseman S; Snyder DE Parasit Vectors; 2021 Jun; 14(1):299. PubMed ID: 34088338 [TBL] [Abstract][Full Text] [Related]
10. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto (fluralaner) against Frontline (fipronil) in flea- and tick-infested dogs. Rohdich N; Roepke RK; Zschiesche E Parasit Vectors; 2014 Mar; 7():83. PubMed ID: 24593931 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of lotilaner (Credelio™) against the adult cat flea, Ctenocephalides felis and flea eggs following oral administration to dogs. Young L; Karadzovska D; Wiseman S; Helbig R Parasit Vectors; 2020 Jan; 13(1):25. PubMed ID: 31937370 [TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned cats in Europe. Cavalleri D; Murphy M; Seewald W; Nanchen S Parasit Vectors; 2018 Jul; 11(1):411. PubMed ID: 30001746 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA. Kryda K; Mahabir SP; Inskeep T; Rugg J Parasit Vectors; 2020 Mar; 13(1):98. PubMed ID: 32113472 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of sarolaner (Simparica Packianathan R; Colgan S; Hodge A; Davis K; Six RH; Maeder S Parasit Vectors; 2017 Aug; 10(1):387. PubMed ID: 28814332 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of sarolaner (Simparica™) against fleas on dogs presented as veterinary patients in the United States. Cherni JA; Mahabir SP; Six RH Vet Parasitol; 2016 May; 222():43-8. PubMed ID: 26947964 [TBL] [Abstract][Full Text] [Related]
16. Assessment of owner-administered monthly treatments with oral spinosad or topical spot-on fipronil/(S)-methoprene in controlling fleas and associated pruritus in dogs. Dryden MW; Ryan WG; Bell M; Rumschlag AJ; Young LM; Snyder DE Vet Parasitol; 2013 Jan; 191(3-4):340-6. PubMed ID: 23021262 [TBL] [Abstract][Full Text] [Related]
17. A randomized, blinded, controlled USA field study to assess the use of fluralaner tablets in controlling canine flea infestations. Meadows C; Guerino F; Sun F Parasit Vectors; 2014 Aug; 7():375. PubMed ID: 25129395 [TBL] [Abstract][Full Text] [Related]
18. Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio™) against Ctenocephalides felis on cats. Cavalleri D; Murphy M; Seewald W; Nanchen S Parasit Vectors; 2018 Jul; 11(1):408. PubMed ID: 30001727 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of an 11.2% spinetoram topical spot-on solution for the control of experimental and natural flea (Ctenocephalides felis) infestations on cats in Europe. Wheeler DW; Trout CM; Thompson CM; Winkle JR; White WH Vet Parasitol; 2018 Jul; 258():99-107. PubMed ID: 30105986 [TBL] [Abstract][Full Text] [Related]
20. The sustained speed of kill of ticks (Rhipicephalus sanguineus) and fleas (Ctenocephalides felis felis) on dogs by a spot-on combination of fipronil and permethrin (Effitix Cvejić D; Schneider C; Neethling W; Hellmann K; Liebenberg J; Navarro C Vet Parasitol; 2017 Aug; 243():52-57. PubMed ID: 28807310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]